RNA-based solutions for environmental monitoring and remediation

Publication ID: 24-11857562_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “RNA-based solutions for environmental monitoring and remediation,” Published Technical Disclosure No. 24-11857562_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857562_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,562.

Summary of the Inventive Concept

The present inventive concept leverages RNA replicon technology to develop innovative solutions for environmental monitoring, remediation, and sustainability, addressing pressing ecological challenges.

Background and Problem Solved

The original patent focused on RNA delivery for immunization. However, the environmental sector faces significant challenges in monitoring and remediating pollution, invasive species, and disease in plants and aquatic ecosystems. The present inventive concept tackles these issues by applying RNA replicon technology to develop novel systems and methods for environmental sustainability.

Detailed Description of the Inventive Concept

The inventive concept comprises four primary aspects: (1) a system for monitoring water quality using underwater sensors and RNA replicon-based data analysis; (2) a method for treating contaminated soil via RNA replicon-encoded proteins that degrade pollutants; (3) a device for detecting biomarkers of disease in plants using portable RNA replicon-based sensors; and (4) a system for improving crop yields through RNA replicon-encoded proteins that enhance plant growth. These innovations harness the power of RNA replicons to trigger immune responses in aquatic organisms, plants, and soil microorganisms, enabling effective environmental monitoring and remediation.

Novelty and Inventive Step

The present inventive concept introduces a paradigm shift by applying RNA replicon technology to environmental applications, departing from the original patent's focus on immunization. The new claims demonstrate a non-obvious and innovative use of RNA replicons, leveraging their immunogenic properties to address ecological challenges.

Alternative Embodiments and Variations

Alternative embodiments may include RNA replicon-based systems for air quality monitoring, waste management, or bioremediation. Variations could involve the use of different RNA replicon architectures, delivery methods, or sensor technologies to adapt to specific environmental contexts.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the environmental sector, with potential applications in water quality monitoring, soil remediation, plant disease detection, and crop yield enhancement. The target market includes government agencies, environmental consulting firms, agricultural companies, and research institutions.

Field of Art

Biotechnology and molecular biology, specifically RNA delivery systems, genetic engineering, and non-viral vector technologies for biological applications

Person of Ordinary Skill (PHOSITA) Profile

A researcher with advanced degrees in molecular biology, biotechnology, or bioengineering, with expertise in RNA manipulation, vector design, and understanding of immunological and genetic delivery mechanisms

Obviousness Rationale

A PHOSITA would recognize that the fundamental RNA replicon technology disclosed in the source patent for immunization can be readily adapted to environmental monitoring and remediation applications. The core technical principles of RNA-based delivery, immune pathway triggering, and non-viral vector technologies are directly transferable across different biological domains. The PTD represents a predictable extension of existing RNA delivery methodologies to solve related technical challenges.

Obvious Combinations & Variations

Source Patent Element
Liposome-based RNA delivery system with specific molecular architecture
PTD Variation
Applying the RNA delivery mechanism to underwater sensors and agricultural drone delivery systems
Obviousness Reasoning
A PHOSITA would recognize that RNA delivery principles are fundamentally consistent across different biological systems, making environmental application a predictable design choice
Source Patent Element
mRNA molecules with specific structural components (5' cap, modified nucleotides)
PTD Variation
Modifying RNA replicons to encode proteins for pollutant degradation and plant growth enhancement
Obviousness Reasoning
Protein encoding via RNA is a well-established technique, and adapting the molecular structure to different functional proteins would be considered routine engineering
Source Patent Element
Immunization approach using RNA to trigger immune pathways
PTD Variation
Using RNA replicons to trigger immune responses in aquatic organisms and plants for monitoring and remediation
Obviousness Reasoning
Extending immune response triggering mechanisms to different biological systems represents a known and predictable technological progression
Source Patent Element
Non-viral RNA delivery techniques
PTD Variation
Implementing non-viral vector delivery for environmental monitoring and soil treatment applications
Obviousness Reasoning
Non-viral delivery methods are well-understood and can be readily adapted to different biological contexts with predictable results
Source Patent Element
RNA-based immunization targeting specific biological pathways
PTD Variation
Creating RNA replicon systems for detecting biomarkers and invasive species in ecological systems
Obviousness Reasoning
Detecting biological markers through RNA-triggered responses is a direct and obvious extension of existing immunological detection technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857562 regarding RNA delivery systems, the present published technical disclosure demonstrates that the application of RNA replicon technologies to environmental monitoring and remediation would have been obvious to a person having ordinary skill in the art at the time of invention. The disclosed variations represent predictable extensions of known RNA delivery and immune pathway triggering methodologies across different biological domains, thus rendering potential claims in this technical space obvious and unpatentable.

Original Patent Information

Patent NumberUS 11,857,562
TitleDelivery of RNA to trigger multiple immune pathways
Assignee(s)GlaxoSmith Kline Biologicals S.A.